pharmaceuticals
pharmaceuticals Articles
With specialty pharmaceutical stocks having the chance to move dramatically higher, three large cap leaders are RBC's favorites now.
Published:
Gilead Sciences reported its third-quarter financial results after the markets closed on Tuesday.
Published:
Last Updated:
Gilead Sciences is set to report its third-quarter financial results after the markets close on Thursday.
Published:
Pfizer and Merck both released their third-quarter earnings on Tuesday morning. So, which drug giant is looking better after earnings?
Published:
Last Updated:
The October 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was mixed.
Published:
The October 15 short interest data have been compared with the previous figures, and short interest mixed in these selected biotech stocks.
Published:
Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.
Published:
Last Updated:
Merckis expected to report its third-quarter financial results before the markets open on Tuesday.
Published:
Last Updated:
Endo International and BioDelivery Sciences have announced that the U.S. Food and Drug Administration (FDA) approved their long-term opioid treatment, Belbuca.
Published:
These biotech stocks 24/7 Wall St. has picked stood out from the rest with at least 25% gains over the course of the past week.
Published:
On Thursday when a generic drug company based in San Diego said it will produce an alternative to the $750 per pill Daraprim.
Published:
24/7 Wall St. screened the Merrill Lynch research universe for pharmaceutical stocks paying solid dividends that are rated Buy, and found four outstanding companies.
Published:
ThinkstockThe U.S. Food and Drug Administration (FDA) issued a warning that hepatitis C treatments, Viekira Pak and Technivie, can cause serious liver injury mostly in patients with underlying...
Published:
Last Updated:
Viventia Bio has filedwith the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Eli Lilly is scheduled to report its third-quarter earnings before the markets open on Thursday.
Published: